Why Axsome Therapeutics Stock Reaches Another High
Axsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
Learn when to buy Bitcoin as a beginner, including timing strategies like dollar-cost averaging and risk-aware entry points.
10,380 articlesAxsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
A single fund's exit from Klaviyo set off a ripple effect that shaved a chunk from the stock after earnings. This art...
A fund exited its Centerra Gold stake after a 150% rally, triggering talks of profit-taking and risk management. This...
A key Senate markup on the CLARITY Act is slated for May 14, with a handful of Democrats deciding whether the bill ad...
What really moved Si-Bone in Q1 2026? Our practical analysis breaks down revenue trends, margins, and the company’s a...
A new Gallup poll finds fewer than half of Americans aged 15-34 believe it’s a good time to look for a job, highlight...
As Insight (NSIT) reports Q1 2026 results, investors seek clarity on revenue drivers and margins. This guide breaks d...
SunPower's Q1 2026 results could set the tone for the year. This guide explains what to watch, which numbers matter, ...
Bank of America lifts Micron Technology's price target to $950, arguing a larger AI data-center market drives sustain...
Tech markets move fast, and leveraged ETFs promise bigger gains. But bigger promises come with bigger risks. This gui...
Investors piled into Nextpower after strong 2026 results and a strategic acquisition. This article breaks down the ca...
When doximity stock plunged today, the market focused on earnings quality and future profitability. This article brea...